Washington, DC - Is old age a disease?  Dan Weber, president of the Association of Mature American Citizens [AMAC], says a significant amount of scientific research indicates that aging is, indeed, a disease.  "More important there are many who believe it is a disease with a cure."

Escondido, California - The population of critically endangered Jamaican iguanas is on the rise, thanks in part to the efforts of researchers at the San Diego Zoo Institute for Conservation Research’s Kenneth and Anne Griffin Reptile Conservation Center—an off-exhibit breeding facility at the San Diego Zoo Safari Park. Since September, four Jamaican iguanas have hatched here from eggs of two different pairs of adult iguanas. One egg from the first clutch hatched Sept. 4 and three eggs from the second clutch hatched Oct. 6, 7 and 11. With the addition of these four new animals, a total of 11 Jamaican iguanas now reside at the Park’s Reptile Conservation Center.

Washington, DC - Interested in finding new customers in international markets, but don’t know where to start? A new video series from the U.S. Commercial Service can help. 

Washington, DC - U.S. Commerce Secretary Wilbur Ross named two small businesses, one city government, and two health care organizations as the 2017 recipients of the Malcolm Baldrige National Quality Award. Celebrating its 30th anniversary this year, the Baldrige Award is a Presidential-level honor, recognizing exemplary practices among American organizations and businesses including an unceasing drive for radical innovation, thoughtful leadership, and administrative improvement. This year’s awardees are proven success stories, providing a rubric for other businesses across the country to follow.

Sacramento, California - California’s three state cannabis licensing authorities announced yesterday that proposed emergency licensing regulations for commercial medicinal and adult-use cannabis have been posted online and are available to the public for review.

Washington, DC - The U.S. Food and Drug Administration announced a comprehensive policy framework for the development and oversight of regenerative medicine products, including novel cellular therapies.